The present disclosure relates to a closure for a container for storing and dispensing matter. The present disclosure more specifically relates to a child resistant closure for a container for storing and dispensing a liquid.
Medicines in the form of a liquid are usually contained within a container that is closed by a child resistant closure that functions to seal the container opening and prevent a child from inadvertently opening the container. To serve the liquid medicine, the liquid medicine must be poured into a separate dispensing device (e.g., a measuring cup, spoon, etc.). Further, the containers typically carry a label that provides a user with instructions as to dosage. The dosage may be dependent upon the age and/or weight of user and is often in confusing and hard to understand terms.
An embodiment of the present disclosure relates to a closure configured to fit over the opening of a receptacle to form a container. The closure includes an inner dosage cup, and an outer cap portion that receives and retains the inner dosage cup, the outer cap portion being rotatable relative to the inner dosage cup and defining at least one viewing window that allows for visual indication of a level of contents within the inner dosage cup.
Another embodiment of the present disclosure relates to a container. The container includes a receptacle having an opening, and a closure configured to fit over the opening of the receptacle. The closure includes an inner dosage cup, and an outer cap portion that receives and retains the inner dosage cup, the outer cap portion being rotatable relative to the inner dosage cup and defining at least one viewing window that allows for visual indication of a level of contents within the inner dosage cup.
A child resistant closure is provided that is configured to be used with a container suitable for retaining a liquid medicine or any other type of liquid for which it may be desirable to measure a relatively small dose of the liquid for consumption or other use. According to the illustrated embodiment, the closure is shown as a two-piece closure that includes an inner dosage cup and an outer cap portion. Together, the inner dosage cup and the outer cap portion provide a device that functions as both a child resistant closure for selectively sealing or closing off an opening of the container, and also as a device that allows for the selective measurement and/or dispensing of the contents of the container.
The inner dosage cup is retained within the outer cap portion, with the outer cap portion being configured for rotational movement relative to the inner dosage cup. To remove the closure from the container, a force is applied to the outer cap portion in the direction of the inner dosage cup (e.g., an axial and/or radial force, etc.). When a sufficient amount of force is applied, the outer cap portion will engage the inner dosage cup such that the outer cap portion and the inner dosage cup rotate as a unit and disengage the closure from the container. If an insufficient amount of force is applied to the outer cap portion, the outer cap portion will simply rotate relative to the inner dosage cup while the closure remains secured to the container, thereby reducing the likelihood that a child will be able to remove the closure.
With the closure removed, a user can turn the closure over and pour the contents of the container into the inner dosage cup. One or more visual indicators may be provided on the outer cap portion and/or the inner dosage cup to help a user identify when a desired amount of the liquid has been poured into the inner dosage cup. According to an exemplary embodiment, one or more openings are provided in the outer cap portion that allows a user to see the level of liquid within the inner dosage cap. Such openings may be sized and shaped such that the areas of the outer cap portion that define the opening may provide a visual indicator as to the level of the contents within the inner dosage cup. After the liquid is poured into the inner dosage cup, the user can use the inner dosage cup as a conventional cup for delivering the contents. Once the liquid has been removed from the inner dosage cup, the closure can be reapplied to the container.
While the closure is shown and described herein as a closure configured to be used with a container configured to retain a liquid, and more particularly a liquid medicine, the closure may also be suitable for use with a container configured a retain solid matter (e.g., powders, etc.), semi-solid matter or any other type of matter.
Before discussing further the details of the closure and components thereof, it should be noted at the outset that references to “front,” “back,” “rear,” “upper,” “lower,” “right,” and “left” in this description are merely used to identify the various elements as they are oriented in the FIGURES, with “front,” “back,” and “rear” being relative to the position of the closure when secured to a container. These terms are not meant to limit the element which they describe, as the various elements may be oriented differently in various applications.
It should further be noted that for purposes of this disclosure, the term “coupled” means the joining of two members directly or indirectly to one another. Such joining may be stationary in nature or moveable in nature and/or such joining may allow for the flow of fluids or communication between the two members. Such joining may be achieved with the two members or the two members and any additional intermediate members being integrally formed as a single unitary body with one another or with the two members or the two members and any additional intermediate members being attached to one another. Such joining may be permanent in nature or alternatively may be removable or releasable in nature.
Referring to
As detailed below, according to an exemplary embodiment, the outer cap portion 80 is configured to provide a user with a visual indication of the proper dosage within the inner dosage cup 40. With the outer cap portion 80 providing a user with a visual indication of the proper dosage within the inner dosage cup 40, the side wall 46 of the inner dosage cup 40 may be relatively free of any markings, projections or recesses that may otherwise be necessary for this purpose. According to the various alternative embodiments, side wall 46 may include one or more graduation marks for the purpose of indicating a correctly measured amount of liquid in the cup. Such graduation marks could be used to measure in terms of ounces, milliliters, cubic centimeters or other preferred units of measure (e.g., child dosage vs. adult dosage, etc.).
Referring to
The coupling portion 44 is sized to fit over and/or around the neck of the container. According to an exemplary embodiment, the coupling portion 44 is in the form of a collar or skirt having a side wall 50 that extends downwardly from the side wall 46. According to an exemplary embodiment, the side wall 50 is concentric with the central axis of the side wall 46 but is displaced or offset radially outwardly from the side wall 46. Defining the transition between the side wall 46 and the side wall 50 is a ledge or shoulder 52. According to an exemplary embodiment, the shoulder 52, like the end wall 48, is substantially perpendicular to a central axis of side wall 46.
The side wall 50 is shown as being substantially cylindrical in shape and having substantially the same cross sectional shape as the side wall 46. The side wall 50 extends in a vertical direction between the shoulder 52 and a bottom edge 54. According to an exemplary embodiment, the bottom edge 54 is in the form of a lip or flange that extends radially outwardly from the side wall 50. The bottom edge 54, like the shoulder 52 and the end wall 48, is substantially perpendicular to a central axis of side wall 46. According to an exemplary embodiment, the bottom edge 54 extends radially outwardly a distance sufficient to at least partially overlap a bottom edge of the outer cap portion 80. According to the embodiment illustrated, the bottom edge 54 has a diameter that is substantially equal to an outer diameter of the outer cap portion 80 at its lowermost edge. Configuring the bottom edge 54 in this manner allows the bottom edge 54 to function as a retaining device that may prevent or limit the axial movement of the inner dosage cup 40 relative to the outer cap portion 80 in a direction towards end wall 48.
According to an exemplary embodiment, the side wall 50 has a truncated conical shape with the side wall 50 being tapered such that the diameter of the side wall 50 near the shoulder 52 is smaller than the diameter of the side wall 50 near the bottom edge 54. According to the various alterative embodiments, the side wall 50 may have any of a variety of shapes and cross sections, including shapes or cross sections that are different than the side wall 46.
Coupling portion 44 includes a first attachment structure or coupling component associated with securing the closure 20 to the container and a second attachment structure or coupling component associated with securing the inner dosage cup 40 to the outer cap portion 80. According to an exemplary embodiment, the first coupling component is provided at an inside surface of the side wall 50, while the second coupling component is provided at an outside surface of the side wall 50.
Referring to
Referring back to
Referring again to
According to an exemplary embodiment, the rib 60 is an annular member that extends outwardly from the outer surface of the side wall 50 and continuously around the periphery of the side wall 50. The cross sectional profile of the rib 60 is shown as being substantially rectangular in shape and has a bottom edge that is located at substantially the same vertical height as the inner shoulder 58. The rib 60 extends radially outwardly a distance sufficient to at least partially engage a corresponding structure (e.g., a projection, groove, etc.) provided on the outer cap portion 80. Configuring the rib 60 in this manner allows the rib 60 to function as a retaining device that may prevent or limit the axial movement the inner dosage cup 40 relative to the outer cap portion 80 in a direction opposite the end wall 48. According to the various alternative embodiments, the rib 60 may be provided intermittently around the periphery of the side wall 50 as one or more segments and/or may have any of a number of cross sectional profiles.
Still referring to
Referring back to
The side wall 86 includes one or more features intended to assist a user in determining whether the desired amount of liquid is within the inner dosage cup 40. According to an exemplary embodiment, the side wall 86 defines one or more openings, shown as windows 90, that extend through the side wall 86. The windows 90, which are shown as including three separate openings that are equally spaced around the periphery of the side wall 86, allow a user to see the inner dosage cup 40 through the side wall 86. By forming at least a corresponding portion of the inner dosage cup 40 of a clear or translucent material, the windows 90 will also allow the user to see the contents of the inner dosage cup 40 and/or the level the of the contents within the inner dosage cup 40.
Any number of the windows 90 may be provided in the side wall 86. Further, the windows 90 may have any of a number of shapes (e.g., rectangular, circular, triangular, etc.). Further still, if more than one window 90 is provided, the windows 90 may have the same or different shapes. According to an exemplary embodiment, the shape of the windows 90 is selected such that the shape itself can be used by the user as a reference or a measuring device for determining whether a proper amount of the liquid has been added to the inner dosage cup 40. According to the embodiment illustrated, the windows 90 are at least partially defined by a first horizontal edge 92 and a second horizontal edge 94. The height of the first horizontal edge 92 relative to the end wall 88 is associated with a first measurement and is provided at a different height than the second horizontal edge 94. The second horizontal edge 94 is associated with a second measurement. For example, the first horizontal edge 92 may represent a level at which liquid should be added to the inner dosage cup 40 for an adult, while the second horizontal edge 94 may represent a level at which liquid should be added to the inner dosage cup 40 for a child.
To further assist a user in determining whether the proper dosage of the liquid has been added to the inner dosage cup 40, the side wall 86 includes one or more graduation marks for this purpose. Such graduation marks could be used to measure in terms of ounces, milliliters, cubic centimeters or other preferred units of measure (e.g., child dosage vs. adult dosage, etc.). According to the embodiment illustrated, the side wall 86 includes a first mark 96 and a second mark 98. The first mark 96 and the second mark 98 each include one or more horizontal line segments extending around the side wall 86 and indicia (e.g., text, numbers, image, etc.) intended to inform the user of the meaning of the horizontal line segment. As shown, the first mark 96 includes the text “ADULT” and is intended to represent the approximate dosage for a typical adult. The horizontal line segment of the first mark 96 is substantially coplanar with the first horizontal edge 92 of the window 90. Similarly, the second mark 98 includes the text “CHILD” and is intended to represent the approximate dosage for a typical child. The horizontal line segment of the first mark 96 is substantially coplanar with the second horizontal edge 94 of the window 90. According to the various alternative embodiments, any number of marks can be provided along the side wall 86 to assist a user in determining whether the proper dosage of the liquid has been added to the inner dosage cup 40.
Referring to
Referring back to
The side wall 100 is shown as being substantially cylindrical in shape and having substantially the same cross sectional shape as the side wall 86. The side wall 100 extends in a vertical direction between the first shoulder 102 and a bottom edge 104. According to an exemplary embodiment, the side wall 100 has a truncated conical shape with the side wall 100 being tapered such that the diameter of the side wall 100 near the first shoulder 102 is smaller than the diameter of the side wall 100 near the bottom edge 104. According to the various alterative embodiments, the side wall 100 may have any of a variety of shapes and cross sections, including shapes or cross sections that are different than the side wall 86.
According to an exemplary embodiment, an outer surface of the side wall 100 includes a gripping surface 106 which is provided to allow the closure 20, and particularly the outer cap portion 80, to be more easily grasped and rotated relative to the inner dosage cup 40 and/or container. According to the embodiment illustrated, the gripping surface 106 includes a series of vertical ribs or corrugations extending around the entire periphery of the side wall 100. According to the various alternative embodiments, the outer surface of the side wall 100 may have a different structure that facilitates gripping of the outer cap portion 80 (e.g., one or more substantially flat sections, etc.) or may not include a gripping structure.
Referring to
With regard to the outer surface of side wall 100, the gripping surface 106 is shown as extending vertically along the side wall 100 both above and below the second shoulder 108. According to the various alternative embodiments, the gripping surface 106 may be selectively provided in only those areas that are above or below the second shoulder 108. Referring to
According to an exemplary embodiment, the rib 112 is an annular member that extends outwardly from the inner surface of the side wall 100 and continuously around the periphery of the side wall 100. The cross sectional profile of the rib 112 is shown as being substantially rectangular in shape, but according to the various alternative embodiments, the rib 112 may be provided intermittently around the periphery of the side wall 100 as one or more segments and/or may have any of a number of cross sectional profiles. The rib 112 is provided near, but is spaced apart from, the bottom edge 104. According to the embodiment illustrated, a plurality of support members 116 are provided to support the rib 112. The support members 116 are shown as extending in a vertical direction around the periphery of the side wall 100 and between the bottom edge 104 and the rib 112. The rib 112 extends radially outwardly at a distance sufficient to at least partially engage the rib 60 provided on the inner dosage cup 40. According to an exemplary embodiment, the rib 112 is configured to engage the rib 60 in a snap-fit manner. Configuring the rib 112 in this manner allows the rib 112 to function as a retaining device that may prevent or limit the axial movement of the inner dosage cup 40 relative to the outer cap portion 80 in a direction opposite the end wall 88.
Still referring to
According to an exemplary embodiment, the second toothings 114 are truncated triangular members that extend from the inner shoulder 110. As shown, each of the second toothings 114 have an angled or sloped first surface 118 and a substantially vertical second surface 120. The angle of the first surface 118 compliments the angle of the first surface 64 of the toothings 62. According to an exemplary embodiment, the first surface 118 and the second surface 120 define an angle therebetween ranging from approximately 30 degrees to approximately 60 degrees. According to the embodiment illustrated, the angle between the first surface 118 and the second surface 120 is approximately 45 degrees and the total number of second toothings 114 extending around the side wall 50 is twenty (20). Thus, the ratio of the first toothings 62 to the second toothings 114 is shown as being 2:1, but alternatively, may be any ratio such as 1:1, 3:1 etc. According to the various alternative embodiments, the second toothings 114 may have any of a variety of shapes, may be provided at any of a number of angles and/or may include more or less toothings than the exemplary embodiment detailed above.
The closure 20 is configured to be assembled by inserting the inner dosage cup 40 into the outer cap portion 80. The inner dosage cup 40 can be inserted into the outer cap portion 80 by axially aligning the two components and moving at least one of the components toward the other component. As the inner dosage cup 40 is being inserted into the outer cap portion 80, the rib 60 on the outer surface of the inner dosage cup 40 is configured to engage and snap over the rib 112 on the inner surface of the outer cap portion 80 by having the side wall 50 flex inwardly. Once the rib 60 has snapped over the rib 112, the side wall 50 returns to its previous shape and the engagement of the rib 60 with the rib 112 limits and/or prevents the axial movement of the inner dosage cup 40 relative to the outer cap portion 80 in a direction opposite the direction of insertion. According to an exemplary embodiment, such insertion is intended to be done by the manufacturer and the engagement between the rib 60 and the rib 112 is not intended to be reversed by a user.
With the inner dosage cup 40 inserted into the outer cap portion 80 and retained relative thereto, the outer cap portion 80 is configured for rotational movement relative to the inner dosage cup 40. To secure the closure 20 to the container, the thread 56 of the inner dosage cup 40 is aligned with a corresponding structure at an open end of the container. A rotative force is then used to turn the outer cap portion 80 in a closing direction (e.g., clockwise, etc.) relative to the container. As the outer cap portion 80 is turned in the closing direction, the second toothings 114 associated with the outer cap portion 80 will engage the first toothings 62 associated with the inner dosage cup 40 such that the inner dosage cup 40 will rotate with the outer cap portion 80. Specifically, the second surface 120 of the second toothings 114 will engage the second surface 66 of the first toothings 62. Together the outer cap portion 80 and the inner dosage cup 40 can be rotated until the closure 20 is secured to the container.
After the closure 20 is secured to the container, when the outer cap portion 80 is rotated in an opening direction (e.g., counterclockwise, etc.), the second toothings 114 associated with the outer cap portion 80 will ratchet or ride up over the first toothings 62 associated with the inner dosage cup 40, thereby preventing rotation of the inner dosage cup 40. Specifically, the first surface 118 of the second toothings 114 will engage the first surface 64 of the first toothings 62, but will ride up over the first toothings 62. Such a configuration is intended to prevent a child from removing the closure 20 from the container.
In order to open the sealed container, the user must apply both a rotative force and a second force to the outer cap portion 80. According to an exemplary embodiment, the second force is axial force in a downward direction. In such an embodiment, it is the axial force that prevents the second toothings 114 of the outer cap portion 80 from ratcheting or riding up over the first toothings 62 of the inner dosage cup 40. Thus, when the outer cap portion 80 is rotated in the opening direction, with the use of both a rotational and axial force, the second toothings 114 engage the first toothings 62 such that the outer cap portion 80 and the inner dosage cup 40 rotate together as a unit. The continual movement of the outer cap portion 80 and the inner dosage cup 40 in this manner will disengage the thread 56 from the container and allow the closure to be removed.
With the closure 20 removed, the user can turn the closure 20 over and pour the contents of the container into the inner dosage cup 40. According to the embodiment illustrated, the user may utilize the window 90, the first horizontal edge 92, the second horizontal edge 94, the first mark 96 and/or the second mark 98 to assist with identifying when a desired amount of the liquid has been poured into the inner dosage cup 40. When the desired amount of liquid has been poured into the inner dosage cup 40, the user can use the closure 20 as a cup and consume the contents directly therefrom. Once the contents of the inner dosage cup 40 have been removed, the closure can be reattached to the container.
It is also important to note that the construction and arrangement of the elements of the closure 20 as shown in the exemplary embodiment is illustrative only. Although only a few embodiments of the present inventions have been described in detail in this disclosure, those skilled in the art who review this disclosure will readily appreciate that many modifications are possible (e.g., variations in sizes, dimensions, structures, shapes and proportions of the various elements, values of parameters, mounting arrangements, use of materials, colors, orientations, etc.) without materially departing from the novel teachings and advantages of the subject matter recited. For example, elements shown as integrally formed may be constructed of multiple parts or elements and those shown a multiple parts may be integrally formed. Accordingly, all such modifications are intended to be included within the scope of the present inventions. Other substitutions, modifications, changes and omissions may be made in the design, operating conditions and arrangement of the preferred and other exemplary embodiments without departing from the spirit of the appended claims.
The order or sequence of any process or method steps may be varied or re-sequenced according to alternative embodiments. Any means-plus-function clause is intended to cover the structures described herein as performing the recited function and not only structural equivalents but also equivalent structures. Other substitutions, modifications, changes and omissions may be made in the design, operating configuration and arrangement of the preferred and other exemplary embodiments without departing from the spirit of the appended claims.
This application claims the benefit of priority to U.S. Provisional Patent Application No. 61/589,156, which was filed on Jan. 20, 2012, the complete disclosure of which is incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
202268 | Keller | Apr 1878 | A |
847726 | Brannon | Oct 1906 | A |
1780875 | Gordon | Nov 1930 | A |
1820817 | McRae | Aug 1931 | A |
1869712 | Palmer | Aug 1932 | A |
2102440 | Sebell | Dec 1937 | A |
2108063 | Hothersall | Feb 1938 | A |
2108692 | Pieck | Feb 1938 | A |
D120154 | Carson | Apr 1940 | S |
D120155 | Carson | Apr 1940 | S |
D136002 | Mas | Jul 1943 | S |
2687157 | Cowan | Aug 1954 | A |
2762526 | Gilmour | Sep 1956 | A |
2778533 | Savary | Jan 1957 | A |
2826343 | Albiani | Mar 1958 | A |
2894654 | Lohrer | Jul 1959 | A |
3013308 | Armour | Dec 1961 | A |
3018931 | Westgate | Jan 1962 | A |
3033407 | Isele-Aregger | May 1962 | A |
D193121 | Wickman | Jun 1962 | S |
3059816 | Goldstein | Oct 1962 | A |
3110410 | Pehr | Nov 1963 | A |
3115994 | Grady | Dec 1963 | A |
3117701 | Stull | Jan 1964 | A |
3131824 | Van Baarn | May 1964 | A |
3135456 | Palazzolo | Jun 1964 | A |
3143256 | Lazure et al. | Aug 1964 | A |
3155285 | Van Baam | Nov 1964 | A |
D200270 | Waterman | Feb 1965 | S |
3180537 | Collins | Apr 1965 | A |
3181746 | Tupper | May 1965 | A |
D204509 | Waterman | Apr 1966 | S |
3262606 | Waterman | Jul 1966 | A |
3322308 | Foster | May 1967 | A |
3323671 | Minarik et al. | Jun 1967 | A |
3351242 | Lodding et al. | Nov 1967 | A |
3412890 | Rich | Nov 1968 | A |
3499588 | Bartilson et al. | Mar 1970 | A |
3542235 | Hidding | Nov 1970 | A |
3563426 | Bartilson | Feb 1971 | A |
3629901 | Wolf | Dec 1971 | A |
3651992 | Hazard | Mar 1972 | A |
3675812 | Foster | Jul 1972 | A |
3782583 | Abbey | Jan 1974 | A |
3851812 | Bittel | Dec 1974 | A |
3860135 | Yung et al. | Jan 1975 | A |
3881639 | Herip | May 1975 | A |
3907156 | Weatherhead, III | Sep 1975 | A |
3912128 | Ziemann et al. | Oct 1975 | A |
3933271 | McGhie | Jan 1976 | A |
3948415 | Debenham | Apr 1976 | A |
3966080 | Bittel | Jun 1976 | A |
3998354 | Song | Dec 1976 | A |
4022352 | Pehr | May 1977 | A |
4029202 | Lasich et al. | Jun 1977 | A |
4040595 | Tecco | Aug 1977 | A |
4082201 | Bittel | Apr 1978 | A |
4106672 | Tecco et al. | Aug 1978 | A |
4127221 | Vere | Nov 1978 | A |
4135404 | Butler, Jr. | Jan 1979 | A |
4163496 | Dogliotti | Aug 1979 | A |
4170315 | Dubach et al. | Oct 1979 | A |
4177932 | Cleevely | Dec 1979 | A |
4183457 | Loughley et al. | Jan 1980 | A |
4223814 | Sneider | Sep 1980 | A |
4236653 | Gach | Dec 1980 | A |
D258052 | Firanzi | Jan 1981 | S |
4253587 | Otterson | Mar 1981 | A |
D258869 | Firanzi | Apr 1981 | S |
4270664 | Buono | Jun 1981 | A |
4274563 | Otterson | Jun 1981 | A |
4280636 | Lewis | Jul 1981 | A |
4284200 | Bush et al. | Aug 1981 | A |
4291818 | Nozawa et al. | Sep 1981 | A |
4308979 | Otterson | Jan 1982 | A |
4318500 | Melikian | Mar 1982 | A |
4326649 | Marino et al. | Apr 1982 | A |
D265060 | Blank | Jun 1982 | S |
4334639 | Gach | Jun 1982 | A |
D266390 | Haner | Oct 1982 | S |
4359171 | Lewis | Nov 1982 | A |
4361250 | Foster | Nov 1982 | A |
4369901 | Hidding | Jan 1983 | A |
D268482 | Mineo | Apr 1983 | S |
4380307 | Stillinger | Apr 1983 | A |
4403712 | Wiesinger | Sep 1983 | A |
4414705 | Ostrowsky | Nov 1983 | A |
D272807 | Ruhl | Feb 1984 | S |
4457458 | Heinol | Jul 1984 | A |
4489864 | Davis | Dec 1984 | A |
D276981 | Cleevely | Jan 1985 | S |
D277458 | Neggers | Feb 1985 | S |
4503991 | Joyce | Mar 1985 | A |
D278602 | Rosenstein | Apr 1985 | S |
4533058 | Uhlig | Aug 1985 | A |
4538731 | Cillario | Sep 1985 | A |
4541541 | Hickman et al. | Sep 1985 | A |
4545495 | Kinsley | Oct 1985 | A |
4545508 | Cribb et al. | Oct 1985 | A |
4550862 | Barker et al. | Nov 1985 | A |
4566508 | Bowyer | Jan 1986 | A |
4566509 | Szajna | Jan 1986 | A |
4573600 | Dubach | Mar 1986 | A |
4610371 | Karkiewicz | Sep 1986 | A |
4629081 | McLaren | Dec 1986 | A |
4648528 | LaBarge et al. | Mar 1987 | A |
4658980 | Lindstrom | Apr 1987 | A |
4660746 | Wright | Apr 1987 | A |
D291411 | Crawford | Aug 1987 | S |
4693399 | Hickman et al. | Sep 1987 | A |
D292882 | Gross | Nov 1987 | S |
4714181 | Kozlowski et al. | Dec 1987 | A |
4718567 | La Vange | Jan 1988 | A |
4723693 | DeCoster | Feb 1988 | A |
4724977 | Cleevely et al. | Feb 1988 | A |
4726091 | Joyce | Feb 1988 | A |
4730731 | Allison | Mar 1988 | A |
4733794 | Kent | Mar 1988 | A |
4735334 | Abbott | Apr 1988 | A |
4735335 | Torterotot | Apr 1988 | A |
4739906 | LoTurco | Apr 1988 | A |
D296081 | Kuboshima | Jun 1988 | S |
4778071 | Fillmore | Oct 1988 | A |
4792054 | Weidman | Dec 1988 | A |
4793501 | Beck | Dec 1988 | A |
4793502 | Beck | Dec 1988 | A |
4802597 | Dubach | Feb 1989 | A |
4813560 | Begley | Mar 1989 | A |
4823995 | Lewis | Apr 1989 | A |
4838441 | Chernack | Jun 1989 | A |
4844302 | Lay | Jul 1989 | A |
4848612 | Beck | Jul 1989 | A |
4854473 | Dubach | Aug 1989 | A |
4881668 | Kitterman et al. | Nov 1989 | A |
D305206 | Hickman et al. | Dec 1989 | S |
4890770 | Haga et al. | Jan 1990 | A |
4898292 | VerWeyst et al. | Feb 1990 | A |
D306701 | Beck | Mar 1990 | S |
4915268 | Lay et al. | Apr 1990 | A |
4919286 | Agbay, Sr. | Apr 1990 | A |
4936494 | Weidman | Jun 1990 | A |
4940167 | Fillmore et al. | Jul 1990 | A |
4955513 | Bennett | Sep 1990 | A |
4984716 | Beck | Jan 1991 | A |
4993606 | Bolen et al. | Feb 1991 | A |
D315307 | Kanyer | Mar 1991 | S |
5007555 | Beck | Apr 1991 | A |
5020686 | Dutt | Jun 1991 | A |
D318778 | Fiore et al. | Aug 1991 | S |
5042658 | Tiramani et al. | Aug 1991 | A |
5048730 | Forsyth et al. | Sep 1991 | A |
D320746 | Bolen et al. | Oct 1991 | S |
D321137 | Hofmann et al. | Oct 1991 | S |
5067624 | Thanisch | Nov 1991 | A |
5078289 | Bolton et al. | Jan 1992 | A |
5083671 | Hayes | Jan 1992 | A |
5085331 | Groya et al. | Feb 1992 | A |
5115929 | Buono | May 1992 | A |
5115931 | Dubach | May 1992 | A |
5139165 | Hara | Aug 1992 | A |
5143234 | Lohrman et al. | Sep 1992 | A |
D331877 | Robichaud et al. | Dec 1992 | S |
D331878 | Forsyth | Dec 1992 | S |
5167338 | Kick | Dec 1992 | A |
5181630 | McNally | Jan 1993 | A |
D333617 | Brown | Mar 1993 | S |
5193704 | Kick | Mar 1993 | A |
5197616 | Buono | Mar 1993 | A |
5211301 | Groya et al. | May 1993 | A |
5219100 | Beck et al. | Jun 1993 | A |
5228596 | McNally | Jul 1993 | A |
D339065 | Forsyth et al. | Sep 1993 | S |
D340187 | Forsyth | Oct 1993 | S |
D340188 | Forsyth | Oct 1993 | S |
5249695 | Luch et al. | Oct 1993 | A |
5261569 | Sandwell | Nov 1993 | A |
5271519 | Adams et al. | Dec 1993 | A |
5305931 | Martin et al. | Apr 1994 | A |
D346958 | Olson | May 1994 | S |
D347974 | McBride | Jun 1994 | S |
5330082 | Forsyth | Jul 1994 | A |
5339993 | Groya et al. | Aug 1994 | A |
5348183 | Luch et al. | Sep 1994 | A |
5356017 | Rohr et al. | Oct 1994 | A |
5370251 | Buono | Dec 1994 | A |
5377882 | Pham et al. | Jan 1995 | A |
5383582 | Baxter et al. | Jan 1995 | A |
D355121 | Kohl | Feb 1995 | S |
5386918 | Neveras et al. | Feb 1995 | A |
5397013 | Adams et al. | Mar 1995 | A |
5423442 | Nozawa et al. | Jun 1995 | A |
5435456 | Dubach | Jul 1995 | A |
D361512 | Dalmaz | Aug 1995 | S |
5464110 | Heyworth | Nov 1995 | A |
5489035 | Fuchs | Feb 1996 | A |
5499736 | Kohl | Mar 1996 | A |
5501348 | Takeuchi | Mar 1996 | A |
5509582 | Robbins, III | Apr 1996 | A |
5513780 | Buono | May 1996 | A |
5531349 | Wojcik et al. | Jul 1996 | A |
5540343 | Schumacher | Jul 1996 | A |
5542579 | Robbins, III | Aug 1996 | A |
5549224 | Wu et al. | Aug 1996 | A |
5558239 | Dubach | Sep 1996 | A |
5566850 | Forsyth et al. | Oct 1996 | A |
5579934 | Buono | Dec 1996 | A |
5579957 | Gentile et al. | Dec 1996 | A |
5588546 | Farside | Dec 1996 | A |
5603421 | Opresco | Feb 1997 | A |
5620107 | Takeuchi | Apr 1997 | A |
5632417 | Robbins et al. | May 1997 | A |
5642824 | Hess et al. | Jul 1997 | A |
5667089 | Moore | Sep 1997 | A |
5667094 | Rapchak et al. | Sep 1997 | A |
5667106 | Robbins, III | Sep 1997 | A |
D385791 | Forsyth et al. | Nov 1997 | S |
5755352 | Wojcik et al. | May 1998 | A |
5758793 | Forsyth et al. | Jun 1998 | A |
5762216 | Takeuchi | Jun 1998 | A |
5785193 | Kobayashi et al. | Jul 1998 | A |
5794803 | Sprick | Aug 1998 | A |
5799838 | Miller | Sep 1998 | A |
5823345 | Nask et al. | Oct 1998 | A |
D404201 | Wennerstrom | Jan 1999 | S |
5865330 | Buono | Feb 1999 | A |
5865353 | Baudin | Feb 1999 | A |
5873493 | Robinson | Feb 1999 | A |
5875907 | Lay | Mar 1999 | A |
5881894 | Gargano | Mar 1999 | A |
5908125 | Opresco | Jun 1999 | A |
5913435 | Fuchs | Jun 1999 | A |
D413064 | Bansal | Aug 1999 | S |
D414698 | Mogard et al. | Oct 1999 | S |
5971231 | Samz et al. | Oct 1999 | A |
5975368 | Wood | Nov 1999 | A |
5996859 | Beck | Dec 1999 | A |
6036036 | Bilani et al. | Mar 2000 | A |
6039224 | Dallas et al. | Mar 2000 | A |
6041477 | Rentsch et al. | Mar 2000 | A |
6102257 | Goyet | Aug 2000 | A |
6116469 | Wallays et al. | Sep 2000 | A |
6152320 | Hierzer et al. | Nov 2000 | A |
6158632 | Ekkert | Dec 2000 | A |
6164503 | Forsyth et al. | Dec 2000 | A |
D436040 | Warner et al. | Jan 2001 | S |
6223946 | Geisinger et al. | May 2001 | B1 |
6250507 | Ekkert | Jun 2001 | B1 |
6250517 | Samz et al. | Jun 2001 | B1 |
6273152 | Buehler et al. | Aug 2001 | B1 |
6276572 | Evans | Aug 2001 | B1 |
6283317 | Benoit-Gonin et al. | Sep 2001 | B1 |
6289906 | Vanden et al. | Sep 2001 | B1 |
6299033 | VerWeyst et al. | Oct 2001 | B1 |
6308870 | Samz et al. | Oct 2001 | B2 |
6321923 | Wood | Nov 2001 | B1 |
6332551 | Copeland | Dec 2001 | B1 |
D453892 | Lindsay et al. | Feb 2002 | S |
6343723 | Hickerson | Feb 2002 | B1 |
RE37634 | Hickman et al. | Apr 2002 | E |
6364169 | Knickerbocker | Apr 2002 | B1 |
6371316 | Herr et al. | Apr 2002 | B1 |
6382476 | Randall et al. | May 2002 | B1 |
6405885 | Elliott | Jun 2002 | B1 |
6439410 | Dubach | Aug 2002 | B1 |
6460712 | Smith et al. | Oct 2002 | B2 |
6460718 | Vogel | Oct 2002 | B1 |
6460726 | Hierzer et al. | Oct 2002 | B1 |
6464113 | Vogel | Oct 2002 | B1 |
6488187 | Sheffler et al. | Dec 2002 | B2 |
D468639 | Wennerstrom et al. | Jan 2003 | S |
6510971 | Martin | Jan 2003 | B1 |
D472138 | Brozell et al. | Mar 2003 | S |
6543649 | Danielo et al. | Apr 2003 | B1 |
6550626 | Randall | Apr 2003 | B1 |
6575323 | Martin et al. | Jun 2003 | B1 |
D476563 | Brozell et al. | Jul 2003 | S |
D476892 | Martin et al. | Jul 2003 | S |
D476897 | Brozell | Jul 2003 | S |
6601740 | Clive | Aug 2003 | B1 |
6612450 | Buono | Sep 2003 | B1 |
6631820 | Harrold et al. | Oct 2003 | B2 |
6644487 | Smith et al. | Nov 2003 | B2 |
6648188 | Brecheisen et al. | Nov 2003 | B2 |
6688501 | DeGroot et al. | Feb 2004 | B2 |
6691901 | Parve et al. | Feb 2004 | B2 |
6705495 | Brecheisen et al. | Mar 2004 | B2 |
6761279 | Martin et al. | Jul 2004 | B1 |
6766926 | Elchert | Jul 2004 | B1 |
6786363 | Lohrman | Sep 2004 | B1 |
6830721 | Martin | Dec 2004 | B2 |
6880736 | Gnepper | Apr 2005 | B1 |
6904867 | Zamjahn | Jun 2005 | B2 |
6935543 | DeGroot et al. | Aug 2005 | B2 |
D509426 | Samz et al. | Sep 2005 | S |
6948643 | Lohrman | Sep 2005 | B1 |
D513983 | Erdie | Jan 2006 | S |
7032632 | Shingle | Apr 2006 | B2 |
7097071 | Anderson et al. | Aug 2006 | B2 |
7134575 | Vogel et al. | Nov 2006 | B2 |
7147020 | Bronner | Dec 2006 | B2 |
7168461 | DeJonge | Jan 2007 | B2 |
7213620 | DeJonge | May 2007 | B2 |
7296700 | Steele et al. | Nov 2007 | B2 |
D562132 | LaMasney | Feb 2008 | S |
7909212 | Parve | Mar 2011 | B2 |
20020079339 | Sheffler et al. | Jun 2002 | A1 |
20030116879 | Mueller et al. | Jun 2003 | A1 |
20040118881 | Brecheisen et al. | Jun 2004 | A1 |
20040134942 | Parve et al. | Jul 2004 | A1 |
20040169307 | Mueller et al. | Sep 2004 | A1 |
20040226950 | Samz et al. | Nov 2004 | A1 |
20050023304 | Vogel et al. | Feb 2005 | A1 |
20060278665 | Bennett | Dec 2006 | A1 |
20080017665 | Brecheisen et al. | Jan 2008 | A1 |
20080142547 | Colacioppo et al. | Jun 2008 | A1 |
20090159544 | Tune | Jun 2009 | A1 |
20100126997 | Stull et al. | May 2010 | A1 |
20110248048 | Fernandez De Mendiola Quintana et al. | Oct 2011 | A1 |
20120085791 | Groubert et al. | Apr 2012 | A1 |
Number | Date | Country |
---|---|---|
1245601 | Nov 1988 | CA |
491014 | Jul 1970 | CH |
37 34 156 | Apr 1988 | DE |
42 39 299 | Mar 1994 | DE |
0 590 325 | Apr 1994 | EP |
0 631 942 | Jan 1995 | EP |
WO-9420713 | Sep 1994 | WO |
Entry |
---|
U.S. Appl. No. 29/416,677, filed Mar. 26, 2012, Vogel et al. |
Number | Date | Country | |
---|---|---|---|
20130193143 A1 | Aug 2013 | US |
Number | Date | Country | |
---|---|---|---|
61589156 | Jan 2012 | US |